Securities notice · Vesalius Longevity Labs is not yet a reporting issuer. The proposed reverse takeover transaction is subject to regulatory and shareholder approvals. Nothing on this site constitutes an offer to sell or solicitation to buy securities.
Share structure and transaction structure.
A reverse takeover is the public listing vehicle. The CSE listing page and SEDAR+ filings remain the definitive sources.
Resulting Issuer Capital Table
Ticker symbolCSE: VLAB (expected at close)
Share structure — June 2026 investor deck
- Shares
- 100,828,965
- Options
- 5,850,000
- RSUs
- 2,000,000
- Warrants
- 10,434,750
- Total diluted I/O
- 119,113,715
- Cash
- US$8 million
- Debt
- N/A